Position in ABT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,691,197
-$1,029,419 QoQ
Shares Held
45,692
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $11,029,250 across 8 Medical Devices names. ABT ranks #1 (42.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
45,692 | $4,691,197 | |
| 2 | SYK |
Stryker Corp
|
6,218 | $2,043,172 | |
| 3 | BSX |
Boston Scientific Corp
|
22,180 | $1,391,795 | |
| 4 | EW |
Edwards Lifesciences Corp
|
11,173 | $894,733 | |
| 5 | MDT |
Medtronic plc
|
9,902 | $858,008 | |
| 6 | PEN |
Penumbra Inc
|
2,466 | $809,760 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,396 | $241,727 | |
| 8 | CATX |
Perspective Therapeutics, Inc.
|
23,707 | $98,858 |
All Filings in ABT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,691,197 | 45,692 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,720,616 | 45,659 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,613,287 | 49,375 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,572,139 | 48,321 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,041,676 | 45,546 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,914,855 | 43,452 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,077,093 | 44,532 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,563,623 | 43,919 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,862,488 | 42,781 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $4,562,841 | 41,454 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $3,980,244 | 41,097 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,825,007 | 44,258 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,511,696 | 34,680 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,387,570 | 30,855 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $2,794,041 | 28,876 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,360,979 | 30,934 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,954,975 | 24,966 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,476,981 | 24,705 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,878,946 | 24,371 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,054,987 | 26,352 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,115,001 | 25,993 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,063,995 | 18,851 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,288,003 | 11,835 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $952,974 | 10,423 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $722,973 | 9,162 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||